Literature DB >> 21123533

Evaluation of CLSI agar dilution method and Trek Sensititre broth microdilution panel for determining antimicrobial susceptibility of Streptococcus pneumoniae.

Sean X Zhang1, Prasad Rawte, Shirley Brown, Steven Lo, Heather Siebert, Sylvia Pong-Porter, Donald E Low, Frances B Jamieson.   

Abstract

Both the CLSI agar dilution method and Trek Sensititre broth microdilution panel for Streptococcus pneumoniae antimicrobial susceptibility testing were evaluated against the reference CLSI broth microdilution method using the most recently published CLSI breakpoints. While agar dilution was not an optimal method, the commercial panel appeared to be an acceptable method, with minor errors encountered for ceftriaxone, penicillin, and meropenem.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21123533      PMCID: PMC3043519          DOI: 10.1128/JCM.01622-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  3 in total

1.  Comparison of MicroScan MICroSTREP, PASCO, and Sensititre MIC panels for determining antimicrobial susceptibilities of Streptococcus pneumoniae.

Authors:  L L Guthrie; S Banks; W Setiawan; K B Waites
Journal:  Diagn Microbiol Infect Dis       Date:  1999-04       Impact factor: 2.803

2.  Evaluation of commercial methods for determining antimicrobial susceptibility of Streptococcus pneumoniae.

Authors:  F C Tenover; C N Baker; J M Swenson
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

3.  Comparison of BSAC agar dilution and NCCLS broth microdilution MIC methods for in vitro susceptibility testing of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: the BSAC Respiratory Resistance Surveillance Programme.

Authors:  Rosy Reynolds; Jemma Shackcloth; David Felmingham; Alasdair MacGowan
Journal:  J Antimicrob Chemother       Date:  2003-10-29       Impact factor: 5.790

  3 in total
  6 in total

1.  Factors associated with ceftriaxone nonsusceptibility of Streptococcus pneumoniae: analysis of South African national surveillance data, 2003 to 2010.

Authors:  Claire von Mollendorf; Cheryl Cohen; Linda de Gouveia; Vanessa Quan; Susan Meiring; Charles Feldman; Keith P Klugman; Anne von Gottberg
Journal:  Antimicrob Agents Chemother       Date:  2014-03-31       Impact factor: 5.191

2.  Klebsiella pneumoniae antibiotic resistance identified by atomic force microscopy.

Authors:  Vincenzo Ierardi; Paolo Domenichini; Silvia Reali; Gian Marco Chiappara; Gianluigi Devoto; Ugo Valbusa
Journal:  J Biosci       Date:  2017-12       Impact factor: 1.826

3.  A real-time PCR antibiogram for drug-resistant sepsis.

Authors:  John R Waldeisen; Tim Wang; Debkishore Mitra; Luke P Lee
Journal:  PLoS One       Date:  2011-12-02       Impact factor: 3.240

4.  High-throughput method for Antibiotic Susceptibility Testing based on Fluorescein Quenching by Bacteria: Application to Urinary Tract Infection.

Authors:  Rohit Radhakrishnan; Rajesh J; Dinesh N S; Thangavelu C P; Sankaran K
Journal:  Sci Rep       Date:  2020-03-04       Impact factor: 4.379

5.  Prevalence and Characterization of Integrons in Multidrug Resistant Acinetobacter baumannii in Eastern China: A Multiple-Hospital Study.

Authors:  Jing Chen; Hong Li; Jinsong Yang; Rong Zhan; Aiping Chen; Yansheng Yan
Journal:  Int J Environ Res Public Health       Date:  2015-08-21       Impact factor: 3.390

6.  Pneumococcal serotypes associated with invasive disease in under five children in India & implications for vaccine policy.

Authors:  V Balaji; Ranjith Jayaraman; Valsan Philip Verghese; P R Baliga; T Kurien
Journal:  Indian J Med Res       Date:  2015-09       Impact factor: 2.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.